White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin

白色脂肪组织生理学、线粒体功能与脂联素 近年来，人们致力于更好地理解棕色和米色 脂肪细胞，典型的特征是线粒体含量高。然而，它的作用是 白色脂肪细胞中的线粒体，超越了基本生理和“家务”，仍然大量存在。 没有特征的。我们已经开发了一些系统，在这些系统中，我们可以解决脂肪细胞特有的 线粒体功能，以一种可诱导的方式。这允许诱导关键的线粒体成分在 成年小鼠，不包括不良的发育影响。在上一个资助期内，我们有 研究了许多模型，在这些模型中，脂肪细胞线粒体功能选择性地增强或 妥协了。我们的一个新模型允许我们特别增强线粒体的活性氧物种 脂肪细胞内的(ROS)水平。这具有深远的局部和系统影响，导致我们得出以下结论 假设：脂肪细胞线粒体ROS水平的降低是 脂肪组织对全身代谢改变的重塑和适应 条件。通过仔细计时和滴定线粒体活性和ROS水平，我们将检查这一点 以下领域的假说：A)成熟脂肪细胞的细胞水平；B)微环境 在整个脂肪组织重塑的水平上；C)在生物体水平上评估 脂肪细胞来源的ROS，特别关注胰岛β细胞。具体地说，我们建议解决 基本机制：在目标1中，我们将审查 脂肪细胞特异性线粒体功能障碍和线粒体在局部细胞上产生的ROS 脂肪细胞的内稳态。在目标2中，我们将定义脂肪细胞特有的线粒体的作用 功能障碍和线粒体产生的ROS对局部脂肪组织微环境、功能和 改建。在目标3中，我们将解决脂肪细胞特异性线粒体功能障碍和 线粒体来源的ROS对系统代谢稳态的影响。综合起来，这些研究使我们能够 仔细剖析线粒体功能改变对脂联素产生、细胞生理学的影响 白色脂肪细胞与脂肪组织适应性重塑。而线粒体的既定作用 棕色脂肪细胞的功能被广泛认识，我们的数据认为线粒体功能的相关性 白色脂肪细胞被错误地低估了。我们已经生成了一个独特的工具集，使我们能够 系统地解决“线粒体功能障碍”的问题，事实上，这个工具包帮助我们 有条不紊地定义“功能障碍”一词。我们还想更好地了解治理机制 脂联素的产生和释放。根据我们的初步数据，我们坚信线粒体 在这一过程中，活动起着至关重要的作用。此外，线粒体ROS对细胞周期的影响也很大 脂肪垫的适应性重塑以及脂肪细胞与胰腺中的β细胞的串扰。

White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin Much attention has been dedicated over recent years towards a better understanding of brown and beige adipocytes, which are classically characterized by high mitochondrial content. However, the role of mitochondria in white adipocytes, beyond basic physiology and “housekeeping”, remains vastly uncharacterized. We have developed systems in which we can address adipocyte-specific manipulation of mitochondrial function, in an inducible fashion. This allows for induction of key mitochondrial components in the adult mouse, excluding undesirable developmental effects. Over the previous funding period, we have examined a number of models in which adipocyte mitochondrial function was selectively enhanced or compromised. One of our new models allows us to specifically enhance mitochondrial reactive oxygen species (ROS) levels within the adipocyte. This has profound local and systemic effects that led us to the following hypothesis: THE LOWERING OF ADIPOCYTE MITOCHONDRIAL ROS LEVELS IS A PREREQUISITE FOR THE REMODELING AND ADAPTATION OF ADIPOSE TISSUE TO ALTERED SYSTEMIC METABOLIC CONDITIONS. By carefully timing and titrating mitochondrial activity and ROS levels, we will examine this hypothesis in the following areas: A) at the cellular level in the mature adipocyte; B) in the microenvironment at the level of whole adipose tissue remodeling; C) at the organismal level assessing systemic effects of adipocyte-derived ROS, with a specific focus on pancreatic beta cells. Specifically, we propose to address the underlying mechanisms with the following hierarchical approaches: In Aim 1, we will examine the effects of adipocyte-specific mitochondrial dysfunction and mitochondria-generated ROS on the LOCAL cellular homeostasis of the adipocyte. In Aim 2, we will define the effects of adipocyte-specific mitochondrial dysfunction and mitochondria-generated ROS on the local ADIPOSE TISSUE microenvironment, function and remodeling. In Aim 3, we will address the effects of adipocyte-specific mitochondrial dysfunction and mitochondria-derived ROS on SYSTEMIC metabolic homeostasis. Combined, these studies enable us to carefully dissect the effects of altered mitochondrial function on adiponectin production, cellular physiology of the white adipocyte and adaptive remodeling of adipose tissue. While the established role of mitochondrial function in brown adipocytes is widely appreciated, our data argues that the relevance of mitochondrial function in the white adipocyte has been mistakenly undervalued. We have generated a unique toolset that allows us to systematically approach the question of “mitochondrial dysfunction” and, in fact, this toolset helps us to methodically define the term “dysfunction”. We also want to better understand the mechanisms governing adiponectin production and release. Based upon our preliminary data, we strongly believe that mitochondrial activity plays an essential role in this process. Furthermore, mitochondrial ROS exerts profound effects on the adaptive remodeling of fat pads as well as on the crosstalk of adipocytes with the beta cells in the pancreas.